Brain Chemistry Altered by Later Life Experience, Part 2
I recently wrote of an informative NBC News article of June 2, 2013 (see part 1 here). Investigative reporter Rebecca Ruiz laid out medical research evidence pointing toward non-genetic alterations in brain chemistry — that is, organic changes in the brain’s chemistry after birth.
Specifically, Ruiz’s article was centered around the behavioral concept of resiliency. She provided medical research and testimony, as well as case study, that early formative experiences may produce structural adaptations to genes
Amazing, that early experiences can have such an impact on the developing physical brain. But what ab...
Source: World of Psychology - June 16, 2013 Category: Psychiatrists and Psychologists Authors: Lisa A. Miles Tags: Addiction Alcoholism Brain and Behavior Depression Disorders General Medications Mental Health and Wellness Psychology Research Substance Abuse Treatment Addictions Agonist Antabuse anxiety Brain Chemistry Brain Structure Source Type: blogs
It’s Getting Harder
The forces of nature appear intent on reversing mankind’s progress toward better health. An example is the ever-increasing resistance of bacteria to antibiotics. A timeline of the existence of humans and bacteria shows that bacteria have been around for a very long time— much longer than mammals, and much, much longer than humans. In fact by the dawn mankind, bacteria [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - May 11, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Buprenorphine disease of addiction drug resistance heroin addiction resistance to treatment Suboxone treatment Source Type: blogs
FDA to Titan: ‘NO’ on Probuphine
A few weeks ago I described Reckitt Benckiser as a ship returning to port, after the FDA ‘bitch-slapped’ the company for a bit of trickery that was intended to block generics from making Suboxone. As an aside… I wondered if ‘bitch-slap’ would be an offensive, misogynist term, or whether it was a fair way to describe what happened [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - May 4, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Buprenorphine Legal Pharma pharmacology Public policy Suboxone treatment new treatments for addiction opioid dependence probuphine suboxone alternatives zubsolv Source Type: blogs
Wating on a Head Trip
I’m always impressed by the power of our ‘unconscious.’ I realize that people have a range of models for conceptualizing how our minds work; my own combination of education, analysis, and observation has led to an understanding that ‘works for me.’ My conscious mind works in series, holding one or two thoughts at a time [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - April 28, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Psychodynamics recovery shame and addiction unconscious mind working through feelings Source Type: blogs
Who Pays?
I realize that practice patterns differ between practices, even those treating the same condition (opioid dependence) with the same medication (buprenorphine). Differing patient characteristics result in different regional standards of care, for example. And some areas have access to services (e.g. group treatments or laboratory testing) that may not be as available somewhere else. Physicians [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - April 20, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Buprenorphine Drug Testing Public policy Suboxone treatment addiction treatment costs buprenorphine testing cost of Suboxone drug test for suboxone urine drug testing Source Type: blogs
Bye, Dad.
My dad passed away two days ago, one day after his 89th birthday. It doesn’t feel quite right to post something so personal. But it feels more wrong to write about anything else. Writing was a source of tension between us in some ways. My perspectives on myself, my parents, and my upbringing have changed [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - April 2, 2013 Category: Addiction Authors: J T Junig Tags: Psychodynamics 'aha' moments childhood memories communication insigt Source Type: blogs
Is ‘Shame’ Always a Bad Thing?
I generally write positive articles about the use of buprenorphine for treating opioid dependence, and my articles have been reflective of my attitude toward the medication. The field of psychiatry encompasses more conditions than it does effective treatments for those conditions, and my initial experiences treating people with buprenorphine were strikingly positive. My first buprenorphine [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - March 23, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Buprenorphine recovery relapse Suboxone treatment character defects shame and addiction shame cycle of addiction Source Type: blogs
An Answer to the Question: What exactly are the current barriers to naloxone access?
I thought I’d post this question from Liz since a lot of people seem to be asking it lately:
Law makers introduced a way to prevent drug overdoses in america, which is now the second leading cause of accidental deaths. One of those ways is to remove the barriers of Naloxone (Narcan) access, does anyone know what those barriers are?In response to mark, I’m actually on the medication, well on suboxone which has naloxone in it. So do you think that’s the one and only barrier to getting it? And I know that you have to go through a program to get it in the first place, in Maine there’s a waiting list. Ma...
Source: Addiction Recovery Blog - March 17, 2013 Category: Addiction Authors: Addiction Recovery Author Tags: Opiate Treatment Source Type: blogs
Suboxone as Problem, Suboxone as Solution
A local District Attorney wrote to me last week to express his concern about the increased diversion of buprenorphine. I often sense an undercurrent of tension when I cross paths with attorneys, aware of the different attitudes that we hold that arise from our different roles in society. The DA wrote about the dramatic increase in [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - March 15, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Buprenorphine Legal pharmacology Psychodynamics Public policy relapse side effects treatment hooked on the needle IV drug abuse Suboxone suboxone abuse suboxone diversion suboxone relapse Source Type: blogs
Suboxone Makes Me Fat and Boring and Stupid
A late post tonight, since my new exercise program has pushed my blogging back by an hour or so each night. My suspicions about exercise were correct, by the way; it is much easier to suggest exercise to other people than it is to actually exercise. I’ve been at it since the beginning of the [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - March 7, 2013 Category: Addiction Authors: J T Junig Tags: Addiction Education Mood recovery side effects Suboxone Subutex treatment Withdrawal anxiety from suboxone exercise and recovery no motivation on suboxone suboxone fat suboxone makes me tired Source Type: blogs
Crazy Week for Suboxone
What a crazy week for buprenorphine. I’ve written about the FDA slapping the face of Reckitt Benckiser by denying their Citizens’ Petition. Adding insult to injury, the FDA then approved two generic formulations of Suboxone tabs (actually, the correct name is buprenorphine/naloxone combination tabs). Stock in RB dropped about 5%, but shares regained most of their price within a [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - March 3, 2013 Category: Addiction Authors: J T Junig Tags: Buprenorphine My book risks side effects Suboxone treatment buprenorphine tablets generic suboxone Reckitt-Benckiser stock price suboxone film suboxone tabs Source Type: blogs
FDA Denies Reckitt Petition Over Generic Suboxone
WE ARE REPEATING THIS FROM THE WEEKEND: In a huge blow to Reckitt Benckiser, the FDA late last week rejected a citizen petition the company had filed last fall in hopes of thwarting generic rivals to its best-selling Suboxone tablet for treating opioid dependence. Moreover, the agency also referred the issue to the US Federal Trade Commission in response to comments filed by generic drug makers that Reckitt had engaged in anticompetitive business practices.
The decision, which was accompanied by FDA approval of two generic versions, caps a long-running controversy over the Reckitt strategy to maintain its Suboxone franchis...
Source: Pharmalot - February 25, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Actavis Amneal Pharmaceuticals FDA Opioid Dependance Reckitt Benckiser Suboxone Source Type: blogs
RB Citizen Petition: Smack Treatment Smack-Down Details
Find a copy of the response here, or at this url: www.suboxonetalkzone.com/cpresponse.pdf (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - February 24, 2013 Category: Addiction Authors: J T Junig Tags: Buprenorphine Public policy Reckitt-Benckiser Suboxone generic suboxone lawsuit against suboxone Reckitt Benckiser citizens petition Source Type: blogs
Reckitt Benckiser Suboxone Citizen’s Petition DENIED by FDA
I’ve written in detail about the bold move by Reckitt-Benckiser that few people outside the company saw coming. In brief, the company has been cruising across the Atlantic for the past ten years, fueled by stellar growth of its flagship medication, Suboxone—even as the expiration of the patent on the medication loomed ahead (y’know– like an iceberg). [...] (Source: Suboxone Talk Zone)
Source: Suboxone Talk Zone - February 23, 2013 Category: Addiction Authors: J T Junig Tags: Buprenorphine Reckitt-Benckiser Suboxone Subutex FDA blocks Reckitt Benckiser generic suboxone Reckitt Benckiser citizens petition rgbpf share price Source Type: blogs
Reckitt Hires Key Bureaucrat Amid Suboxone Tumult
Amid a raging controversy over its strategy for promoting the Suboxone treatment for opioid dependence, Reckitt Benckiser has hired a career government bureaucrat who can help the company better navigate the curious world of opioid treatment programs and federal regulations. In a little-noticed move, Nicholas Reuter joined Reckitt earlier this month as manager of treatment health policy and government affairs, a Reckitt spokesman confirms.
Reuter, who spent 37 years with the federal government, was most recently a senior public health analyst with the Substance Abuse & Mental Health Service Administration, or SAMHSA. ...
Source: Pharmalot - February 21, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized FDA Nicholas Reuter Nick Reuter Reckitt Benckiser SAMHSA Suboxone Source Type: blogs
